68
Participants
Start Date
September 15, 2025
Primary Completion Date
November 28, 2025
Study Completion Date
December 1, 2025
a combination serum containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES
Subjects were randomized to receive a combination serum The combination serum contained Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES. applied twice daily, following QS-Nd:YAG 1064 nm low-fluence laser treatment. Clinical evaluations were conducted at baseline and at Weeks 1, 2, and 4 post-laser to assess pigmentation improvement, erythema, and overall skin condition.
2% hydroquinone cream
Subjects were randomized to received 2% hydroquinone cream, applied once daily at night, following QS-Nd:YAG 1064 nm low-fluence laser treatment. Clinical evaluations were conducted at baseline and at Weeks 1, 2, and 4 post-laser to assess pigmentation improvement, erythema, and overall skin condition.
Gatot Soebroto Central Army Hospital, Jakarta Pusat
Dr.dr.Irma Bernadette, SpKK (K)
OTHER